The median (range) frequency of Ki67 expression in the evaluable cases was 80% (50–90%), which was higher than that in NSCLC cases.1 Therefore, in terms of NE markers, mitosis and Ki67 expression, our cases in this study were consistent with possible LCNEC. This evidence concerns the gene MKI67 and large cell neuroendocrine carcinoma.